title: In reply.
authors.affiliation: <sup>*</sup>Tarleton State University, Fort Worth, TX.
authors.forename: Sally
authors.initials: S
authors.lastname: Hoger
authors.affiliation: <sup>*</sup>Tarleton State University, Fort Worth, TX.
authors.forename: Kristine
authors.initials: K
authors.lastname: Lykens
authors.affiliation: <sup>‡</sup>Centers for Disease Prevention and Control, Atlanta, GA USA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Beavers
authors.affiliation: <sup>‡</sup>Centers for Disease Prevention and Control, Atlanta, GA USA.
authors.forename: Dolly
authors.initials: D
authors.lastname: Katz
authors.affiliation: <sup>†</sup>University of North Texas Health Science Center<break/>Fort Worth, TX.
authors.forename: Thaddeus
authors.initials: T
authors.lastname: Miller
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D055985:Latent Tuberculosis / Q000401:mortality*; D008136:Longevity; D008297:Male; D014376:Tuberculosis / Q000401:mortality*
chemical_list: D000995:Antitubercular Agents